Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.（CRNX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crnx · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$105
Consensus
$85.83
+155.6% upside
Low
$67.00
Median: $85.5 · Last Close: $33.59
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$85.83
155.6% upside
High Target
$105
212.6%
Low Target
$67
99.5%
Current Price
$33.59
as of today
Based on analyst price targets, the CRNX stock price prediction for the next 12 months ranges from $67 to $105. The consensus CRNX price forecast of $85.83 implies 155.6% upside from the current price of $33.59.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $32.12 | ↓ 4.36% |
1-day model range: $31.9–$32.35. Peak: $32.35 (-4.36%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $36 | +6.9% |
| 2028 | $37 | +11.4% |
| 2029 | $38 | +14.2% |
| 2030 | $39 | +15.9% |
| 2031 | — | +16.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRNX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-11 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-05-08 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-28 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-02 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-01-12 | Goldman Sachs | Upgrade ↑ | Neutral→Buy |
| 2026-01-08 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-01-06 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-11-07 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-09-30 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Crinetics Pharmaceuticals, Inc. (CRNX) stock. Of the recent 80 rating actions, 3 were upgrades and 0 were downgrades. 18 analysts currently cover CRNX.
分析师推荐趋势
CRNX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$69M
↓ 83.7% YoY
Revenue Next Year
$173M
↑ 152.4% YoY
EPS This Year
$-4.80
EPS Next Year
$-4.21
↓ 12.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRNX EPS of $-4.80 for the current fiscal year, based on estimates from 10 analysts. The CRNX revenue forecast is $69M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRNX 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRNX 的共识目标价为 $85.83（+155.6% 上行空间），分析师共识为 Buy。
CRNX 的短期预测（明日）为 $32.12（-4.36%）。 CRNX 对 2027 年的股价预测均值为 $36。 CRNX 对 2030 年的预测区间为 $36–$42。
Crinetics Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 CRNX。CRNX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CRNX 预测 · 8 个问题根据 18 位华尔街分析师，CRNX 的 12 个月平均目标价为 $85.83，最高 $105.00、最低 $67.00。若有图表，中位目标价可在上方查看。相对当前价 $33.59，隐含约 +155.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.